| Polyunsaturated fatty acids and their derivatives: therapeutic value for inflammatory, functional gastrointestinal disorders, and colorectal cancer A Michalak, P Mosińska, J Fichna Frontiers in pharmacology 7, 459, 2016 | 99 | 2016 |
| Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders A Tarasiuk, P Mosińska, J Fichna Chinese medicine 13, 1-11, 2018 | 78 | 2018 |
| The mechanisms linking obesity to colon cancer: An overview A Tarasiuk, P Mosińska, J Fichna Obesity research & clinical practice 12 (3), 251-259, 2018 | 78 | 2018 |
| Common links between metabolic syndrome and inflammatory bowel disease: current overview and future perspectives A Michalak, P Mosińska, J Fichna Pharmacological Reports 68 (4), 837-846, 2016 | 62 | 2016 |
| Cannabinoid receptor type 1 and mu-opioid receptor polymorphisms are associated with cyclic vomiting syndrome A Wasilewski, U Lewandowska, P Mosinska, C Watala, M Storr, J Fichna, ... Official journal of the American College of Gastroenterology| ACG 112 (6 …, 2017 | 56 | 2017 |
| Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice M Sałaga, U Lewandowska, D Sosnowska, PK Zakrzewski, ... Naunyn-Schmiedeberg's archives of pharmacology 387, 1069-1078, 2014 | 49 | 2014 |
| Expression and physiology of opioid receptors in the gastrointestinal tract P Mosinska, M Zielinska, J Fichna Current Opinion in Endocrinology, Diabetes and Obesity 23 (1), 3-10, 2016 | 42 | 2016 |
| Free fatty acid receptors as new potential therapeutic target in inflammatory bowel diseases A Bartoszek, E Von Moo, A Binienda, A Fabisiak, JB Krajewska, ... Pharmacological Research 152, 104604, 2020 | 41 | 2020 |
| Preliminary randomized controlled trial of antiaging effects of l‐ascorbic acid applied in combination with no‐needle and microneedle mesotherapy M Zasada, A Markiewicz, Z Drożdż, P Mosińska, A Erkiert‐Polguj, ... Journal of Cosmetic Dermatology, 0 | 37 | |
| Bile acids and FXR in functional gastrointestinal disorders P Mosińska, A Szczepaniak, J Fichna Digestive and Liver Disease 50 (8), 795-803, 2018 | 29 | 2018 |
| Dual functional capability of dendritic cells–cytokine-induced killer cells in improving side effects of colorectal cancer therapy P Mosińska, A Gabryelska, M Zasada, J Fichna Frontiers in pharmacology 8, 126, 2017 | 24 | 2017 |
| One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool? JB Krajewska, J Fichna, P Mosińska Critical Reviews in Oncology/Hematology 132, 1-8, 2018 | 23 | 2018 |
| Relamorelin and other ghrelin receptor agonists-future options for gastroparesis, functional dyspepsia and proton pump inhibitors-resistant non-erosive reflux disease H Zatorski, P Mosinska, M Storr, J Fichna J Physiol Pharmacol 68 (6), 797-805, 2017 | 21 | 2017 |
| Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice M Salaga, H Zatorski, M Zielińska, P Mosinska, JP Timmermans, ... Naunyn-Schmiedeberg's Archives of Pharmacology 390, 1015-1027, 2017 | 20 | 2017 |
| Future treatment of constipation-associated disorders: role of relamorelin and other ghrelin receptor agonists P Mosińska, H Zatorski, M Storr, J Fichna Journal of Neurogastroenterology and Motility 23 (2), 171, 2017 | 20 | 2017 |
| Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review P Mosińska, M Salaga, J Fichna Expert opinion on investigational drugs 25 (3), 275-286, 2016 | 20 | 2016 |
| Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice P Mosińska, K Socała, D Nieoczym, M Laudon, M Storr, J Fichna, P Wlaź Behavioural Brain Research 307, 199-207, 2016 | 19 | 2016 |
| Ischemic colitis: current diagnosis and treatment P Mosinska, J Fichna Current drug targets 16 (3), 209-218, 2015 | 19 | 2015 |
| Activation of free fatty acid receptor 4 affects intestinal inflammation and improves colon permeability in mice M Salaga, A Bartoszek, A Binienda, JB Krajewska, A Fabisiak, ... Nutrients 13 (8), 2716, 2021 | 16 | 2021 |
| Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron M Martín‐Ruíz, JA Uranga, P Mosinska, J Fichna, K Nurgali, ... Neurogastroenterology & Motility 31 (3), e13499, 2019 | 15 | 2019 |
